WHO ICTRP trial
Multicenter cooperative and investigator initiated clinical trial using valproic…
JPRN-jRCT2091220259 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCT2091220259 |
|---|---|
| Public title | Multicenter cooperative and investigator initiated clinical trial using valproic acid in childhood onset spinal muscular atrophy : Continuous administration trial |
| Scientific title | Multicenter cooperative and investigator initiated clinical trial using valproic acid in childhood onset spinal muscular atrophy : Continuous administration trial - SMART03 |
| Primary sponsor | Institute of Medical Genetics, Tokyo Women's Medical University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 2B |
| Countries | Japan |
| Conditions | spinal muscular atrophy |
| Interventions | Intervention type:DRUG Name of intervention:SMART Dose form / Japanese Medical Device Nomenclature:GRANULES Route of administration / Site of application:ORAL Dose per administration:12.5 or 25 mg/kg Dosing frequency / Frequency of use:QD… |
| Registration date | Oct 8, 2016 |
| Target size | 28 |
| Secondary IDs | JMA-IIA00259 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: